Zacks Investment ResearchThu, 30 Apr 2026 15:55:14 GMTGlaukos Gains on Q1 Earnings Beat & Improved 2026 Revenue OutlookGKOS+22.84%
Seeking AlphaThu, 30 Apr 2026 03:21:32 GMTGlaukos Corporation (GKOS) Q1 2026 Earnings Call TranscriptGKOS+22.84%
Zacks Investment ResearchThu, 30 Apr 2026 02:00:22 GMTGlaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesGKOS+22.84%
Zacks Investment ResearchWed, 29 Apr 2026 23:41:50 GMTGlaukos (GKOS) Reports Q1 Loss, Tops Revenue EstimatesGKOS+22.84%
Zacks Investment ResearchThu, 16 Apr 2026 15:26:05 GMTGlaukos Wins Permanent J-Code for Epioxa Keratoconus TherapyGKOS+22.84%
Zacks Investment ResearchFri, 20 Mar 2026 14:35:34 GMTGlaukos Launches Epioxa, Boosts Growth in Corneal TreatmentsGKOS+22.84%
Zacks Investment ResearchThu, 19 Mar 2026 16:31:21 GMTWhy Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?GKOS+22.84%
Zacks Investment ResearchWed, 18 Feb 2026 16:55:15 GMTGlaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue OutlookGKOS+22.84%
BenzingaWed, 18 Feb 2026 14:34:54 GMTThese Analysts Boost Their Forecasts On Glaukos Following Q4 ResultsGKOS+22.84%
Seeking AlphaWed, 18 Feb 2026 04:14:57 GMTGlaukos Corporation (GKOS) Q4 2025 Earnings Call TranscriptGKOS+22.84%
Zacks Investment ResearchWed, 18 Feb 2026 00:01:32 GMTGlaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to SayGKOS+22.84%
Zacks Investment ResearchTue, 17 Feb 2026 23:25:26 GMTGlaukos (GKOS) Reports Q4 Loss, Beats Revenue EstimatesGKOS+22.84%
Zacks Investment ResearchTue, 10 Feb 2026 16:00:54 GMTGlaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy?GKOS+22.84%
The Motley FoolSat, 31 Jan 2026 21:46:46 GMTDirector Sells GKOS 15,000 Shares for $1.9 MillionGKOS+22.84%
